Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

[The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].

Schürhoff F, Fond G, Berna F, Bulzacka E, Godin O, Boyer L, Misdrahi D, Andrianarisoa M, Brunel L, Coulon N, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Rey R, Lancon C, Passerieux C, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Encephale. 2019 Feb;45(1):9-14. doi: 10.1016/j.encep.2018.07.007. Epub 2018 Oct 13. French.

PMID:
30327207
2.

Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.

Fond G, Berna F, Boyer L, Godin O, Brunel L, Andrianarisoa M, Aouizerate B, Capdevielle D, Chereau I, Danion JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Gloahec T, Llorca PM, Mallet J, Misdrahi D, Rey R, Richieri R, Passerieux C, Portalier C, Roux P, Vehier A, Yazbek H, Schürhoff F, Bulzacka E; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):17-26. doi: 10.1007/s00406-017-0787-9. Epub 2017 Mar 27.

PMID:
28349247
3.

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.

Fond G, Berna F, Andrianarisoa M, Godin O, Leboyer M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Richieri R, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):465-472. doi: 10.1007/s00406-017-0771-4. Epub 2017 Feb 25.

PMID:
28238173
4.

Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.

Fond G, Godin O, Schürhoff F, Berna F, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Boyer L, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Psychiatry Res. 2018 Dec;270:104-110. doi: 10.1016/j.psychres.2018.09.024. Epub 2018 Sep 13.

PMID:
30245372
5.

Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.

Fond G, Boyer L, Schürhoff F, Berna F, Godin O, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Schizophr Res. 2018 Nov;201:373-380. doi: 10.1016/j.schres.2018.05.007. Epub 2018 May 27.

6.

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.

Fond G, Godin O, Brunel L, Aouizerate B, Berna F, Bulzacka E, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Strat Y, Micoulaud-Franchi JA, Misdrahi D, Rey R, Richieri R, Passerieux C, Schandrin A, Schürhoff F, Tronche AM, Urbach M, Vidalhet P, Llorca PM, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

J Affect Disord. 2016 Feb;191:209-15. doi: 10.1016/j.jad.2015.11.017. Epub 2015 Nov 26.

PMID:
26674214
7.

Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.

Fond G, Boyer L, Favez M, Brunel L, Aouizerate B, Berna F, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq, Faget C, Gabayet F, Laouamri H, Lancon C, Le Strat Y, Misdrahi D, Rey R, Passerieux C, Schandrin A, Schurhoff F, Tronche AM, Urbach M, Vidalhet P, Llorca PM, Pelissolo A; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Psychopharmacology (Berl). 2016 Feb;233(4):571-8. doi: 10.1007/s00213-015-4167-8. Epub 2015 Dec 3.

PMID:
26630993
8.

Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.

Mallet J, Le Strat Y, Schürhoff F, Mazer N, Portalier C, Andrianarisoa M, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubreucq J, Faget C, Gabayet F, Lançon C, Llorca PM, Misdrahi D, Rey R, Roux P, Schandrin A, Urbach M, Vidailhet P, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):332-339. doi: 10.1016/j.pnpbp.2017.06.026. Epub 2017 Jun 27.

PMID:
28663115
9.

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.

Fond G, Resseguier N, Schürhoff F, Godin O, Andrianarisoa M, Brunel L, Bulzacka E, Aouizerate B, Berna F, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Lançon C, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):541-553. doi: 10.1007/s00406-017-0847-1. Epub 2017 Nov 10.

PMID:
29127503
10.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
11.

[Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].

Sauvanaud F, Kebir O, Vlasie M, Doste V, Amado I, Krebs MO.

Encephale. 2017 May;43(3):235-240. doi: 10.1016/j.encep.2015.12.028. Epub 2016 Sep 19. French.

PMID:
27658989
12.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
13.

Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.

Fond G, Godin O, Boyer L, Berna F, Andrianarisoa M, Coulon N, Brunel L, Bulzacka E, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Schürhoff F, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group.

Eur Arch Psychiatry Clin Neurosci. 2018 May 28. doi: 10.1007/s00406-018-0908-0. [Epub ahead of print]

PMID:
29808267
14.

Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls.

Morisano D, Wing VC, Sacco KA, Arenovich T, George TP.

Am J Addict. 2013 Jan;22(1):46-53. doi: 10.1111/j.1521-0391.2013.00313.x.

PMID:
23398226
15.

Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.

Fond G, Boyer L, Andrianarisoa M, Godin O, Brunel L, Bulzacka E, Coulon N, Llorca PM, Berna F, Aouizerate B, Capdevielle D, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Misdrahi D, Rey R, Richieri R, Roux P, Passerieux C, Schandrin A, Tronche AM, Vidailhet P, Leboyer M, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Schizophr Res. 2018 May;195:529-533. doi: 10.1016/j.schres.2017.08.058. Epub 2017 Sep 6.

PMID:
28888362
16.

Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.

Fond G, Tinland A, Boucekine M, Girard V, Loubière S, Auquier P, Boyer L; French Housing First Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:84-89. doi: 10.1016/j.pnpbp.2018.08.024. Epub 2018 Aug 25.

PMID:
30153497
17.

Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.

Fond G, Boyer L, Andrianarisoa M, Godin O, Bulzacka E, Berna F, Brunel L, Coulon N, Aouizerate B, Capdevielle D, Chereau I, D'amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Leignier S, Mallet J, Misdrahi D, Rey R, Lancon C, Passerieux C, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Schurhoff F, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:62-68. doi: 10.1016/j.pnpbp.2018.04.007. Epub 2018 Apr 17.

PMID:
29678770
18.

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.

Berna F, Misdrahi D, Boyer L, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Danion JM, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Lancon C, Mallet J, Rey R, Passerieux C, Schandrin A, Schurhoff F, Tronche AM, Urbach M, Vidailhet P, Llorca PM, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Schizophr Res. 2015 Dec;169(1-3):255-261. doi: 10.1016/j.schres.2015.10.040. Epub 2015 Nov 15.

PMID:
26589388
19.

Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.

Rey R, D'Amato T, Boyer L, Brunel L, Aouizerate B, Berna F, Capdevielle D, Chereau I, Chesnoy-Servanin G, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Lancon C, Mallet J, Misdrahi D, Passerieux C, Schandrin A, Schürhoff F, Urbach M, Vidailhet P, Llorca PM, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Eur Arch Psychiatry Clin Neurosci. 2017 Sep;267(6):567-577. doi: 10.1007/s00406-017-0779-9. Epub 2017 Apr 7.

PMID:
28389889
20.

Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.

Fond G, Boyer L, Berna F, Godin O, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Schürhoff F, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Br J Psychiatry. 2018 Aug;213(2):464-470. doi: 10.1192/bjp.2018.87. Epub 2018 Jun 6.

PMID:
29871707

Supplemental Content

Support Center